Why is Aristo Bio-Tech falling/rising?

As of 15-Sep, Aristo Bio-Tech & Lifescience Ltd is experiencing a price increase, currently at 140.00, reflecting a rise of 4.0 or 2.94%. The stock has shown strong performance today, outperforming its sector by 2.89%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The delivery volume on September 12 has surged by 127.27% compared to the 5-day average, suggesting increased investor participation. Over the past week, the stock has gained 7.69%, and over the past month, it has risen by 21.74%, significantly outperforming the Sensex, which has only increased by 1.20% and 1.78% in the same periods, respectively. There are no positive or negative factors explicitly listed, but the overall performance metrics indicate a favorable sentiment towards the stock.
In the broader market context, Aristo Bio-Tech's recent performance stands out against the benchmark, as it has significantly outpaced the Sensex in both the short-term and long-term returns. While the stock has increased by 7.69% over the past week and 21.74% over the past month, the Sensex has only managed gains of 1.20% and 1.78% during those same periods. Year-to-date, Aristo Bio-Tech has a return of 5.26%, which is slightly below the Sensex's 6.02%, but its one-year return of 33.33% contrasts sharply with the Sensex's decline of 1.13%. This strong relative performance suggests that investor confidence in Aristo Bio-Tech remains robust, contributing to its rising stock price.